I aim to deliver a comprehensive oncology service by incorporating scientific research from the laboratory into cancer care and provide direct access to state-of-the-art clinical trials.
A/Prof Jim Coward is a medical oncologist and Associate Professor of Medicine at UQ School of Medicine and Mater Research, TRI. He is based at Icon Cancer Care South Brisbane, Southport and Chermside, and has a strong focus on the holistic care of patients with a wide variety of malignancies, in particular gynaecological, head and neck, gastrointestinal and lung cancers.
Completing his medical training at Imperial College, London in 1998, A/Prof Coward became a member of the Royal College of Physicians in 2002. His interest in the field of oncology began during his tenure as a junior doctor and he subsequently undertook specialist registrar training at Westmead Hospital, Sydney and the world renowned Royal Marsden Hospital, London.
In 2006, A/Prof Coward was appointed as a MRC clinical fellow at the Barts Cancer Institute, London, where his research on the effects of immunotherapy in advanced ovarian cancer successfully translated into a clinical trial in patients with platinum resistant disease. This work culminated in a PhD award from Queen Mary, University London in 2010, cementing A/Prof Coward’s desire to dedicate his career to cancer research. He has over 30 peer-reviewed publications and book chapters with numerous citations in leading scientific and clinical journals. Alongside his continuing supervision of clinical trainees and PhD students, A/Prof Coward is a regular lecturer at national conferences.
A/Prof Coward is actively involved in a number of high calibre international research collaborations with clinicians and scientists within prominent international cancer institutes. In addition, as a passionate advocate of gynaecological cancer research, A/Prof Coward speaks at charity events and public forums educating patients and their relatives about his research, and proactively seeks to increase public awareness about ovarian cancer.
For further detail, please visit cowardoncology.com.au
A/Prof Coward is heavily invested in providing cutting edge medicines through a rapidly evolving phase one research portfolio. Supported by Icon Cancer Foundation, he has a predominant focus on immunotherapy based clinical trials for all solid tumour types.